Two China-US Life Science Investment Firms, Wuxi Ventures And Frontline, Will Merge

Published: May 23, 2017

Two prominent China-US healthcare investment firms plan to join forces: WuXi Healthcare Ventures and Frontline BioVentures will merge to form 6 Dimensions Capital. Together, the two firms have almost $800 million under management. 6 Dimensions plans to continue growing by starting two new funds, one dollar-based and the other renminbi. Dr. Ge Li, Chairman and CEO of WuXi AppTec, will serve as Chairman of 6 Dimensions, and Dr. Leon Chen, Managing Partner of Frontline, will be the firm's CEO. WuXi Ventures has focused on innovative US startups, while Frontline is an established China venture firm.

Back to news